Home

Mesothelioma

Mesothelioma Treatment

Mesothelioma Specialists

Clinical Trials

Managing Your Care

Veterans Resources

NEWS ABOUT PHARMACEUTICALS IN MESOTHELIOMA TREATMENT

  1. Scientists Find Cell Process That Causes Mesothelioma
  2. Immune Response Inhibitor Identified in Cancer Retroviruses
  3. MRIs Effective in Identifying Malignant Testicular Cancer Growths
  4. National Comprehensive Cancer Network Announces New Mesothelioma Guidelines
  5. New Type of Cancer Vaccine May Revolutionize Treatment of Some Cancers
  6. Survey Sheds Light on Severity of Breakthrough Cancer Pain
  7. Mesothelioma Vaccine Proven Safe
  8. Personalized Mesothelioma Vaccine Tested in Humans - article at Oncolink
  9. New Treatments for Mesothelioma Show Promise
  10. Cancer Scientists Isolate Fingerprint of Individual Tumors
  11. High Cancer Costs Keep Patients From Seeking Treatment
  12. Clinical Trials Starting Soon for Mesothelioma Drug
  13. Mesothelioma Drug Phase II Trials Starting Soon in Australia
  14. Targeting B-Cell Surface Proteins to Fight Cancer
  15. Mesothelioma and Cancer Research - Human Epidermal Growth Factor Receptor (HER) Signaling and Cancer Therapy
  16. Preparing for surgery - details to consider
  17. Mesothelioma and Cancer Research - the Hedgehog signaling pathway and cancer therapy
  18. Predicting the Effectiveness of Avastin
  19. New Mesothelioma Detection Test Ready for Distribution
  20. Mesothelioma Medication Alimta Receives Approval from UK Health Officials for Lung Cancer
  21. New Maintenance Therapy Methods for Lung Cancer
  22. Scientists at Karmanos Center Isolate Cause of Pleural Pain in Mesothelioma and Other Asbestos Diseases
  23. New Chemotherapy Combination to be tested on Mesothelioma Patients
  24. New Method Shows Promise in Improving Diagnostic Biomarker Cancer Tests
  25. Finnish Study Could Lead to Better Lung Cancer Drug
  26. New Lung Cancer Drug Starts Phase II Clinical Trial
  27. Gene Screening Proves Effective in Screening for Mesothelioma Survival
  28. Ohio University Finds Bond between Asbestos, Human Cell Tissue - Could Lead to Understanding of Mesothelioma Pathogenesis
  29. New Drug Regimen Aimed at Reducing Chemotherapy-Induced Nausea
  30. Ranpirnase and Doxorubicin Form Effective Second Line Treatment for Malignant Mesothelioma
  31. Gene Expression Ratio Test Can Predict Survival in Mesothelioma Cases
  32. Personalized Treatment Prolongs Survival For Advanced Cancer Patients
  33. BWH Researchers Identify Mutated Genes Unique to Mesothelioma Tumors - Brigham and Women's Hospital
  34. Cancer Diagnosis From a Single Drop of Blood?
  35. National mesothelioma virtual bank
  36. Another Study Links Nanotubes To Mesothelioma
  37. Retrofitted Antibodies Shrink Cancer Tumors and May Lead to HIV Vaccine
  38. FDA Tells Manufacturers to Stop Marketing Bogus Cancer Cures
  39. Morphotek Commences Phase II Study of MORAb-009 for Patients with MPM
  40. Research Shows Altered Immune Cells Target Mesothelin
  41. UK researchers predict rates of lung cancer will drop 20% over the next 20 years
  42. Breakthrough Could Lead to New Cancer Therapies
  43. Gene Fusions May Be Unique Identifier for Cancer
  44. Study Examines Interactions Between Asbestos Fibers and Cells
  45. Liver Tumors Treated with Chemotherapy Beads
  46. Mesothelioma Researcher Receives Two Grants
  47. The War on Mesothelioma: Researchers Announce Promising Results of Mesothelin-Based Immunotherapy
  48. Synthetic Material Attaches to Cells to Assist in Cancer Research
  49. Blood Vessel Growth Slowed with Common Chemotherapy Drugs, Slow Spread of Cancer
  50. FDA Recommends Additional Clinical Trial for Onconase
  51. ZenBio Awarded Phase II SBIR Grant for Cell Development
  52. Researchers gain new insight into DNA replication
  53. Study bolsters argument for treating cancer-related fatigue with exercise
  54. Study finds new chemotherapies to be ineffective in fighting asbestos-related cancer
  55. Researchers report promising gene that causes cancer cells to self destruct
  56. EPA awards $2.1 million asbestos research grant
  57. Cancer research may exclude older patients
  58. Vitamin supplements may not help prevent cancer
  59. New treatments under development for asbestos-related cancer
  60. Cancer treatment errors happen more than commonly known
  61. Scientists develop nanotube technology to fight cancer cells
  62. Study Shows Brief Inhibition of Cancer Cells is Effective
  63. Rosetta Genomics offers MicroRNA-based mesothelioma diagnostic test
  64. Vitamin trials for cancer prevention offer disappointing results
  65. Supressing tumors in young patients may increase cancer risk in later years
  66. Mistakes in Treatment Prompt Thorough Review in Southern Australia Hospitals
  67. Researchers Discover Enzyme That Signals Breast Cancer Metastasis
  68. Woman Campaigns for UK Chemoembolisation Trials After Successful Treatment
  69. Clinical trials struggling to attract participants
  70. Study finds chemotherapy may be harmful For patients with advanced cancer
  71. New cancer studies call anti-angiogenesis process into question
  72. Scientists explore ways to use genes to fight cancer
  73. Researchers find molecule that causes malignant cells to self-destruct
  74. Research sheds light on lung cancer for non-smokers
  75. Doctors look toward screening for lung cancer
  76. Nanomaterial Screening helps determine which particles are toxic
  77. Experts: Current pain treatment not sufficient for cancer patients
  78. Massage could be beneficial for reducing cancer pain
  79. New findings about chemotherapy at the molecular level
  80. Transdermal patch developed for severe cancer pain
  81. Too much Vitamin C may interfere with chemotherapy
  82. New clues on causes of thoracic cancer
  83. Telomerase gene sequence uncovered
  84. Pleurodesis in the treatment and care of mesothelioma patients
  85. Epigenetic drugs for cancer treatment
  86. Study shows Alimta effective for maintenance therapy
  87. Scientists announce advance in immunotherapy
  88. Minimally invasive RFA treatment could be used for several cancer types
  89. Novel strategy for cancer treatment uses patient's own blood
  90. Attacking cancer stem cells a way to treat cancer
  91. Predicting cancer-fighting abilities by computer
  92. Anti-inflammatory drugs investigated for chemoprevention
  93. Modified chemotherapy agent improves PET scan functioning
  94. Government budget cuts deter progress in fight against cancer
  95. Navelbine and cisplatin/pemetrexed in treatment of pleural mesothelioma
  96. Tumor Generator Could Enhance Cancer Drug Development
  97. Belgian doctors hit personalized cancer treatment milestone
  98. New biomarkers for cancer developed
  99. New cancer medicines track records fail to live up to hype
  100. New research initiative to map genetic mutations behind cancer
  101. Study suggests antioxidant supplements can have negative effects for cancer treatment patients.
  102. Personalized medicine holds promise
  103. Arenegyr Receives Orphan Drug Designation for Mesothelioma
  104. Onconase Phase IIIb Trial Posts Mixed Results
  105. Study finds inaccuracies in some cancer treatment research.
  106. Piroxicam and Cisplatin Show Promise Against Mesothelioma CellsCarbon nanotubes may be as deadly as asbestos
  107. New Study Tells Researchers How Cancer Spreads
  108. Researchers uncover reasons for patients' adverse reactions to Cetuximab.
  109. Study: Chemotherapy may not have any positive results on mesothelioma sufferers
  110. Synthetic Molecules May Help Battle Cancer
  111. Scientists Take a New Look at the Benefits of Fasting when Undergoing Chemotherapy
  112. Exercise Shown to Fend Off Fatigue Caused by Cancer
  113. Nanoparticles Could Deliver Cancer Drugs
  114. Meta-analysis of cancer clinical trials finds 41 percent are superior to existing treatments
  115. Vinflunine Shows Promise in Treating Malignant Pleural Mesothelioma
  116. Synthetic Molecules Could Offer A Lower Cost Cancer Treatment Alternative
  117. "Bacteria Therapy" Shows Promise in Initial Tests
  118. New UCLA Machine May Kill Cancer Cells
  119. Study raises doubts about some DNA-based drugs
  120. Disease-Causing Bugs May Help Treat Cancer
  121. New Cancer Vaccine Approved for Limited Use in Russia
  122. New Therapy Targets Hepatitis C
  123. Innovative New Cancer Treatment Idea Earns $1 Million Prize
  124. Higher Doses of Chemotherapy Make No Difference in Small Cell Lung Cancer
  125. Nanoparticles Help Advance Anticancer siRNA Therapy
  126. Research at MIT Shows microRNA's Protective Role
  127. Patients See Benefit From Self Reporting Symptoms Online
  128. Cancer drugs from genetically modified chicken eggs
  129. Researchers attempting to figure out how cancer grows
  130. Antifolates - Chemotherapy drugs
  131. Dopamine for cancer treatment
  132. Concerns about anemia medications for cancer patients
  133. Researchers Developing New Ways of Detecting Cancer
  134. Recentin Study Ends
  135. Phase II Study of Sutent ® Results Out
  136. Terminally Ill Cancer Patients Given Hope in UK
  137. New Finding on Correlation Between Angiogenesis, Breast Cancer and Inflammation
  138. PET Found to be effective in the Evaluation of Cancer Treatment
  139. One-tird of cancer patients experience chronic fatigue after treatment
  140. New Drug Cocktails Hold Promise for Cancer, HIV Treatments.
  141. New DNA Discovery Changes the Way Doctors Look at Cancer.
  142. Inraperitoneal Hyperthermic Chemotherapy for Those Suffering With Abdominal Cancer
  143. Mouse Model For Mesothelioma Reproduces Human Disease
  144. Researchers Use Transcriptome Analysis by 454 Sequencing to Identify Tumor Specific Mutations Linked to Malignant Pleural Mesothelioma
  145. Pre-Clinical Data Show Intracellular Pathways Affected by Onconase
  146. Remembering a researcher’s legacy on asbestos research
  147. PET proves effective in evaluating cancer treatment
  148. Trial on experimental antifolate PDX (Pralatrexate)
  149. American College of Physicians releases guidelines for end-of-life care
  150. Web-based system helps doctors track outpatients’ chemotherapy toxicity
  151. NICE Gives Final Approval for Alimta
  152. Par Pharmaceuticals licenses Onconase
  153. Thalidomide and Alimta to be Combined in New Clinical Trial
  154. Alfacell Updates Status Of ONCONASE(R) Phase III Clinical Program
  155. ONCONASE(R) has Potential as Chemopreventive Agent in Mesothelioma
  156. Boysenberries might impede mesothelioma
  157. Diagnostic Tools For Lung And Mesothelioma Cancers To Be Developed
  158. New Mesothelioma Research Center to Open in Sydney
  159. Virotherapy to Treat Mesothelioma
  160. MIT researchers' "nanocell" delivers a toxic double whammy to tumors
  161. FDA Approves the MESOMARK® Assay for the Management of Mesothelioma Patients
  162. NYU School of Medicine Verifies Mesothelioma Diagnostic Test
  163. Researchers Identify Intracellular Pathway of Alfacell's Onconase
  164. New Study Heralds Shortened Timeline for Anticancer Drug Development
  165. Talcum Powder Stunts Tumor Growth
  166. Soluble mesothelin in effusions a strong indicator of mesothelioma
  167. Diagnostic Tools For Lung And Mesothelioma Cancers To Be Developed
  168. New Technology For Cancer Screening Listens For The Signs Of Cancer
  169. Onconase(®) is in its final phase 3 trial for treatment of patients with unresectable malignant mesothelioma
  170. Data Affirm Benefit of ALIMTA(®) for Patients With Malignant Pleural Mesothelioma
  171. New diagnostic tool for mesothelioma to be developed: test will extract microRNAs from a simple blood draw
  172. The Barbara Ann Karmanos Cancer Institute announces significant scientific findings related to Malignant Mesothelioma
  173. Mild Hyperthermia Enhances Antitumor Effects of Ranpirnase
  174. Study shows Mesomark effective for monitoring Mesothelioma
  175. FDA Grants Orphan Drug status to Onconase for Mesothelioma
  176. Alfacell Corporation Files for U.S. Orphan Drug Designation for Onconase
  177. Additional Data From a Phase I Trial of XL647 in Patients With Advanced Solid Tumors
  178. New study on the safety, tolerability, pharmacokinetics and preliminary efficacy of INNO-305
  179. More evidence that patients treated with Onconase have greater median survival times than patients treated with doxorubicin alone
  180. Zolinza becomes first approved HDAC inhibitor
  181. Alimta Researchers Recognized As Heroes Of Chemistry
  182. Progress on Clinical Development Program for ONCONASE(R) in Malignant Mesothelioma
  183. FDA tells Eli Lilly that their Alimta brochure is misleading
  184. News about onocology product candidate SS1P (renamed CAT-5001)
  185. New Research Shows Unique Promise of Onconase in the Prevention and Treatment of Mesothelioma
  186. CuraGen and TopoTarget Announce Initiation of NCI-sponsored Phase II Clinical Trial with PXD101 for Mesothelioma
  187. Alfacell Provides Update on ONCONASE Phase IIIb Confirmatory Registration Trial; Releases First Interim Analysis Data
  188. Alfacell Achieves Full Patient Enrollment Milestone for the Onconase Phase IIIb Registration Study in Unresectable Malignant Mesothelioma
  189. Scientist Reveals His Hopes for Better Tumour Treatment
  190. Alfacell Drug Trial Ahead of Schedule
  191. Alfacell Forms New Thoracic Cancer Advisory Board
  192. Update on Onconase Clinical Program
  193. Promising Research in Early Detection of Mesothelioma
  194. Morphotek Announces IND Submission for MORAb-009, a Monoclonal Antibody for the Treatment of Mesothelin-Expressing Cancers
  195. INNOVIVE Pharmaceuticals Licenses WT1 Peptide Cancer Immunotherapeutic from Memorial Sloan-Kettering Cancer Center
  196. Gene Drug Gives Mesothelioma Patient Second Chance
  197. Novel therapies for pleural mesothelioma
  198. Thoracic Cancer Patients Find New Reasons for Hope with Alimta(®)
  199. MesotheliomaWeb News Stories

Read excerpts from medical publications

News

Resources

 

This website is certified by Health On the Net Foundation. Click to verify.This site complies with the HONcode standard for trustworthy health information: verify here

If you would like to receive a FREE information packet or have questions about mesothelioma, call us at:

Toll-Free 1-877-367-6376

Last updated Thu, 07/01/2010 - 16:07